James M. Frincke

James M. Frincke appears in our data through filings on Hollis Eden Pharmaceuticals Inc /DE/ shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 13 February 2006 to 28 October 2011.

The open-market side counts 3 purchases for €8,010 alongside 4 sales for €4,919. Purchases outweigh sales by €3,091. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2011 alone, the filings show 3 purchases and no sales.

A typical purchase (the median) is worth €2,822. Ninety days after publication, 3 purchases show a median change of -36.8%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.

Most recently, on 31 October 2011, the filings show an open-market purchase worth €2,822 in Hollis Eden Pharmaceuticals Inc /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.